文献速递关节外科

局部双膦酸盐减少骨水泥髋臼假体周围迁移和透亮线的形成

Local bisphosphonate reduces migration and formation of radiolucent lines adjacent to cemented acetabular components.
PubMed 文献 · Bone Joint J · 2017-01-01

这项随机安慰剂对照双盲试验纳入60例全髋关节置换术患者,在骨水泥固定髋臼假体前用浸有伊班膦酸钠或生理盐水的纱布压迫髋臼骨床。伊班膦酸钠组假体最大总点迁移和股骨头移动均较安慰剂组降低约一半(p=0.001和0.004),术后一年完全透亮线在伊班膦酸钠组30例中仅3例,安慰剂组28例中13例(p=0.002),Harris髋关节评分和WOMAC评分无显著影响。

要点

  • 局部伊班膦酸钠使骨水泥髋臼假体最大总点迁移和股骨头移动较安慰剂组降低约一半(p=0.001和0.004)。
  • 术后一年完全透亮线伊班膦酸钠组30例中3例,安慰剂组28例中13例(p=0.002)。
  • Harris髋关节评分和WOMAC评分未见显著影响。

核心结论

  • 考虑到RSA预测骨水泥髋臼假体松动的效力以及透亮线提示松动风险的可能性,这些数据提示局部双膦酸盐治疗可降低晚期无菌性松动的风险。

研究设计与样本

  • 随机安慰剂对照双盲试验,共纳入60例参与者,在骨水泥固定髋臼假体前即刻将浸有双膦酸盐溶液(伊班膦酸钠)或生理盐水的纱布压迫于髋臼骨床。
  • 在3、6、12和24个月随访时进行放射立体照相测量分析(RSA)、透亮线分类、Harris髋关节评分(HHS)和西安大略和麦克马斯特大学骨关节炎指数(WOMAC)评估。

主要发现

  • 以最大总点或股骨头移动测量时,伊班膦酸钠组骨水泥髋臼假体相对骨盆的迁移较安慰剂组降低近一半(p=0.001和0.004)。
  • 术后一年透亮线分类为无、部分或完全,与治疗相关(rho 0.37;p=0.004)。
  • 伊班膦酸钠组30例中仅3例出现完全透亮线,安慰剂组28例中13例(p=0.002)。
  • HHS或WOMAC评分未见显著影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Post-operative migration of cemented acetabular components as measured by radiostereometric analysis (RSA) has a strong predictive power for late, aseptic loosening. Also, radiolucent lines predict late loosening. Migration has been reduced by systemic bisphosphonate treatment in randomised trials of hip and knee arthroplasty. Used as a local treatment, a higher local dose of bisphosphonate can be achieved without systemic exposure. We wished to see if this principle could be applied usefully in total hip arthroplasty (THA). PATIENTS AND METHODS: In this randomised placebo-controlled, double-blinded trial with 60 participants, we compressed gauze soaked in bisphosphonate solution (ibandronate) or saline against the acetabular bone bed immediately before cementing the acetabular component. RSA, classification of radiolucent lines, the Harris Hip Score (HHS) and the Western Ontario McMasters Universities Osteoarthritis Index (WOMAC) were carried out at three-, six-, 12-, and 24-month follow-up. RESULTS: Migration of the cemented acetabular component relative to the pelvis was reduced by movement almost half in the ibandronate group, when measured as maximum total point or as movement of the femoral head (p = 0.001 and 0.004, respectively). Radiolucent lines after one year were classified as absent, partial or complete, and correlated with treatment (rho 0.37; p = 0.004). Only three of 30 patients in the ibandronate group had complete lines, compared with 13 of 28 in the placebo group (p = 0.002). There were no significant effects on HHS or WOMAC score. CONCLUSION: Considering the power of RSA to predict loosening of cemented acetabular components, and the likelihood that radiolucent lines indicate risk of loosening, these data suggest that local treatment with a bisphosphonate can reduce the risk of late aseptic loosening. Cite this article: Bone Joint J 2017;99-B:317-24.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Schilcher J, Palm L, Ivarsson I, et al. Local bisphosphonate reduces migration and formation of radiolucent lines adjacent to cemented acetabular components. Bone Joint J. 2017. PMID: 28249970. doi:10.1302/0301-620X.99B3.BJJ-2016-0531.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。